Filtros de búsqueda

Lista de obras de John Radford

90Yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: updated results after a median follow-up of 7.3 years from the International, Randomized, Phase III First-LineIndolent trial.

artículo científico publicado en 2013

A doxorubicin-based regimen used in the treatment of elderly patients with high-grade non-Hodgkin's lymphoma

artículo científico publicado en 2000

A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B-cell lymphoma

artículo científico publicado en 2013

A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma

artículo científico publicado en 2015

A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy

artículo científico publicado en 2018

A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma

artículo científico publicado en 2000

A phase II trial of AZD1152 in relapsed/refractory diffuse large B-cell lymphoma.

artículo científico publicado en 2015

A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma.

artículo científico publicado en 2001

A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancer

artículo científico publicado en 1991

A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia

artículo científico publicado en 2011

A randomized study of interferon α-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphoma

artículo científico publicado en 2013

A statistical framework for analyzing hypothesized interactions between cells imaged using multispectral microscopy and multiple immunohistochemical markers ⬇️

artículo científico publicado el 30 de marzo de 2013

A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicity

scientific article published on 17 October 2013

A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands.

artículo científico publicado en 2009

A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma

artículo científico publicado en 2009

Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours

artículo científico publicado en 2008

Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.

artículo científico publicado en 2016

Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial

artículo científico publicado en 2012

An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients ⬇️

artículo científico publicado en 2016

An audit of primary surgical treatment for women with ovarian cancer referred to a cancer centre.

artículo científico publicado en 1999

An integrated characterization of serological, pathological, and functional events in doxorubicin-induced cardiotoxicity

artículo científico publicado en 2014

Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma

artículo científico publicado en 2011

Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab.

artículo científico publicado en 2005

Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study

Bacteria-eradicating therapy for ocular adnexal MALT lymphoma: questions for an open international prospective trial.

artículo científico publicado en 2006

Bendamustine can be a bridge to allogeneic transplantation in relapsed Hodgkin lymphoma refractory to brentuximab vedotin.

artículo científico publicado en 2016

Bortezomib therapy in patients with relapsed or refractory lymphoma: potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity

artículo científico publicado en 2006

Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study

artículo científico publicado en 2012

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma

artículo científico publicado en 2017

Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center

artículo científico publicado en 2012

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma: An updated review of published data from the named patient program

artículo científico publicado en 2016

Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial

Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study

scientific article published on 01 March 2020

Burkitt's lymphoma of an ileal pouch following restorative proctocolectomy

scientific article published on 31 January 2012

Case report: enlargement of a mediastinal mass during treatment for Hodgkin's disease may be due to accumulation of fluid within thymic cysts

scientific article published on 01 January 1995

Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial.

artículo científico publicado en 2017

Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?

artículo científico publicado el 1 de julio de 1992

Chemotherapy for ovarian cancer--a consensus statement on standard practice. ⬇️

artículo científico publicado en 1998

ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease.

artículo científico publicado en 2002

Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions.

artículo científico publicado en 2006

Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study).

artículo científico publicado en 2014

Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study).

scientific article published on 24 February 2014

Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling

artículo científico

Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519).

artículo científico publicado en 2005

Comparison of Outcomes in Studies of Advanced Hodgkin's Lymphoma

artículo científico publicado en 2006

Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma

artículo científico publicado en 2010

Consolidation radiotherapy in patients with advanced Hodgkin's lymphoma: survival data from the UKLG LY09 randomized controlled trial (ISRCTN97144519).

artículo científico publicado en 2010

Current knowledge and future research directions in treatment-related second primary malignancies

artículo científico publicado en 2014

De novo treatment of diffuse large B-cell lymphoma with rituximab, cyclophosphamide, vincristine, gemcitabine, and prednisolone in patients with cardiac comorbidity: a United Kingdom National Cancer Research Institute trial.

artículo científico publicado en 2013

Discussing factors associated with quality of life in cancer follow-up appointments: a preliminary test of a pragmatic model for clinical practice ⬇️

artículo científico publicado en 2018

Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes.

artículo científico publicado en 2018

Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

artículo científico publicado en 2000

Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphoma

artículo científico publicado en 2010

European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma.

artículo científico publicado en 2016

Experience of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma and relapsed/refractory systemic anaplastic large-cell lymphoma in the Named Patient Program: Review of the literature

artículo científico

Fatigue, sexual function and mood following treatment for haematological malignancy: the impact of mild Leydig cell dysfunction.

artículo científico publicado en 2000

Fertility after treatment for cancer. Questions remain over ways of preserving ovarian and testicular tissue

artículo científico publicado en 1999

Follow up policy after treatment for Hodgkin's disease: too many clinic visits and routine tests? A review of hospital records.

artículo científico publicado en 1997

Fractionated ⁹⁰Y-ibritumomab tiuxetan radioimmunotherapy as an initial therapy of follicular lymphoma: an international phase II study in patients requiring treatment according to GELF/BNLI criteria.

artículo científico publicado en 2013

Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes

artículo científico publicado en 1999

Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer ⬇️

artículo científico publicado el 1 de mayo de 1990

HL-339 Camidanlumab Tesirine: Updated Efficacy and Safety in an Open-Label, Multicenter, Phase 2 Study of Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (R/R cHL)

HL-507 First-Line Brentuximab Vedotin Plus Chemotherapy Improves Overall Survival in Patients With Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1

How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?

artículo científico publicado en 2011

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.

artículo científico publicado en 2018

Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sa

artículo científico publicado en 2003

Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety

scientific article published on 01 June 2018

Infection risk in patients with small cell lung cancer receiving intensive chemotherapy and recombinant human granulocyte-macrophage colony-stimulating factor

artículo científico publicado en 1992

Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519).

artículo científico publicado en 2009

International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury.

artículo científico publicado en 1999

Isolation of germ cells from human testicular tissue for low temperature storage and autotransplantation

artículo científico publicado en 2001

Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial

artículo científico publicado en 2016

Limited-stage disease: optimal use of chemotherapy and radiation treatment.

artículo científico publicado en 2008

Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results

artículo científico publicado en 2015

Lung cancer after treatment for Hodgkin's lymphoma: a systematic review

artículo científico publicado en 2005

MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression

artículo científico publicado en 2005

Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma

scientific article published on 01 January 2020

Metastatic carcinoma of uncertain primary site: a retrospective review of 57 patients treated with vincristine, doxorubicin, cyclophosphamide (VAC) or VAC alternating with cisplatin and etoposide (VAC/PE).

artículo científico publicado en 1994

Microarray gene expression analysis of fixed archival tissue permits molecular classification and identification of potential therapeutic targets in diffuse large B-cell lymphoma.

artículo científico

Mitomycin C and vinblastine in the treatment of advanced breast cancer

scientific article published on 01 December 1985

Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study

artículo científico publicado en 2007

Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000).

artículo científico publicado en 2013

Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy

artículo científico publicado en 2007

Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study.

artículo científico publicado en 2016

Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study.

artículo científico publicado en 2012

Outcome of Elderly Patients with Diffuse Large B-cell Lymphoma Treated with R-CHOP: Results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial

artículo científico publicado en 2017

Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study.

artículo científico publicado en 2015

Outcomes following front-line chemotherapy in peripheral T-cell lymphoma: 10-year experience at The Royal Marsden and The Christie Hospital

artículo científico publicado en 2017

Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study

artículo científico publicado en 2016

Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation

artículo científico publicado en 2001

Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma

PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study

artículo científico publicado en 2016

PET-Directed Therapy for Hodgkin's Lymphoma

artículo científico publicado en 2015

PLK1 and YY1 interaction in follicular lymphoma is associated with unfavourable outcome

artículo científico publicado en 2013

Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: A two centre study

artículo científico publicado en 2000

Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup analysis

artículo científico publicado en 2020

Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors.

artículo científico publicado en 2007

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma

artículo científico publicado en 2017

Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial

artículo científico publicado en 2005

Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma

artículo científico publicado en 2010

Phase III Trial of Two Investigational Schedules of Ifosfamide Compared With Standard-Dose Doxorubicin in Advanced or Metastatic Soft Tissue Sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Stud

article

Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma

artículo científico publicado en 2008

Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study

scientific article published on 21 May 2019

Precision medicine in diffuse large B-cell lymphoma: hitting the target.

artículo científico publicado en 2015

Predicting septic complications of chemotherapy: an analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsis

artículo científico publicado en 1992

Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group

artículo científico publicado en 2007

Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma.

artículo científico publicado en 2017

Pseudoautosomal linkage of familial Hodgkin's lymphoma: molecular analysis of a unique family with Leri-Weill dyschondrosteosis and Hodgkins lymphoma

scientific article published on 01 April 2003

Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma

artículo científico publicado en 2016

QuantiGene Plex Represents a Promising Diagnostic Tool for Cell-of-Origin Subtyping of Diffuse Large B-Cell Lymphoma

artículo científico publicado en 2015

R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial

artículo científico publicado en 2019

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group

artículo científico publicado en 2001

Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy

artículo científico publicado en 2001

Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.

artículo científico publicado en 2017

Re-treatment with I-131 tositumomab in patients with non-Hodgkin's lymphoma who had previously responded to I-131 tositumomab

artículo científico publicado en 2005

Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost ⬇️

artículo científico publicado el 1 de abril de 1998

Response evaluation in gastrointestinal stromal tumours treated with imatinib: misdiagnosis of disease progression on CT due to cystic change in liver metastases

scientific article published on 01 August 2006

Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comor

artículo científico publicado en 2020

Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting

artículo científico

Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma

artículo científico publicado en 2015

Retrospective analysis of cancer patients admitted to a tertiary centre with suspected neutropenic sepsis: Are C-reactive protein and neutrophil count useful prognostic biomarkers?

artículo científico publicado en 2017

Risk of premature menopause after treatment for Hodgkin's lymphoma.

artículo científico publicado en 2014

Rituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20(+) diffuse large B-cell lymphoma: final analysis of the collaborative trial in relapsed aggressive lymphoma

artículo científico publicado en 2012

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles

artículo científico publicado en 2013

Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial

artículo científico publicado en 2016

Second Cancers after Treatment for Hodgkin's Lymphoma--Continuing Cause for Concern

artículo científico publicado en 2015

Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study

artículo científico publicado en 2011

Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials

artículo científico publicado en 2006

Semen cryopreservation, utilisation and reproductive outcome in men treated for Hodgkin's disease

artículo científico publicado en 2002

Short duration immunochemotherapy followed by radioimmunotherapy consolidation is effective and well tolerated in relapsed follicular lymphoma: 5-year results from a UK National Cancer Research Institute Lymphoma Group study.

artículo científico

Single-agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a UK phase II study suggest activity and possible gender differences.

artículo científico publicado en 2012

Suitability of cisplatin solutions for 14-day continuous infusion by ambulatory pump

artículo científico publicado en 1992

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

artículo científico publicado en 2013

The clinical features, management and prognosis of primary and secondary indolent lymphoma of the bone: a retrospective study of the International Extranodal Lymphoma Study Group (IELSG #14 study)

artículo científico publicado en 2014

The clinical features, management and prognostic effects of pathological fractures in a multicenter series of 373 patients with diffuse large B-cell lymphoma of the bone.

artículo científico publicado en 2013

The impact of mild Leydig cell dysfunction following cytotoxic chemotherapy on bone mineral density (BMD) and body composition

scientific article published on 01 May 2000

The role of computed tomography in the management of ovarian tumours of borderline malignancy

scientific article published on 01 April 1997

The stability of ifosfamide in aqueous solution and its suitability for continuous 7-day infusion by ambulatory pump

artículo científico publicado en 1990

The stability of ifosfamide in aqueous solution and its suitability for continuous 7-day infusion by ambulatory pump

artículo científico publicado en 1991

The value of bone marrow examination in the staging of Hodgkin's lymphoma: a review of 955 cases seen in a regional cancer centre

artículo científico publicado en 2002

Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphoma.

artículo científico publicado en 2004

Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma.

artículo científico publicado en 2018

Treatment for Early-Stage Hodgkin Lymphoma: Has Radiotherapy Had Its Day? ⬇️

artículo científico publicado el 24 de septiembre de 2012

Treatment of Hodgkin lymphoma in older patients

artículo científico publicado en 2015

Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma

artículo científico publicado en 1999

Treatment pathways and resource use associated with recurrent Hodgkin lymphoma after autologous stem cell transplantation.

scientific article published on 16 January 2017

Ultrastructural preservation of ovarian cortical tissue cryopreserved in dimethylsulfoxide for subsequent transplantation into young female cancer patients

artículo científico publicado en 2004

Weekly versus twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenström macroglobulinaemia

artículo científico publicado en 2010

XVI. Early stage Hodgkin lymphoma.

artículo científico

YY1 expression predicts favourable outcome in follicular lymphoma

scientific article published on 25 November 2010

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda